820 likes | 3.59k Views
Haemovigilance. Muhammad Saleh Basharahil Hospital Profile. Road Map. Blood Transfusion Indication .. Are we OVERDOING IT ? Haemovigilance / WHO Strategy on Use of Blood Blood transfusion as a High Risk Process. Why ? Patient safety Dimension on Blood Transfusion
E N D
Haemovigilance Muhammad Saleh Basharahil Hospital Profile
Road Map • Blood Transfusion Indication .. Are we OVERDOING IT ? • Haemovigilance / WHO Strategy on Use of Blood • Blood transfusion as a High Risk Process. Why? • Patient safety Dimension on Blood Transfusion • Blood Transfusion Auditing • Take home message
Is Our Indication Efficient ? Blood Transfusion is efficient only by respecting the STRICT INDICATION
Haemovigilance HaemovigilanceDefinition : Is required to identify and prevent occurrence or recurrence of transfusion related unwanted events, to increase the safety, efficacy and efficiency of blood transfusion, covering all activities of the transfusion chain from donor to recipient." WHO DEFINITION
International Adverse eventsRelated to BT Based on the World Alliance for Patient safety (2005) YEARLY WORLDWIDE 6Million Hepatitis B related to Blood Transfusion. 5 Million Hepatitis C related to BT 160.000 HIV Infection 400 Documented cases of contracting nosocomial HIV in the Libyan children due to invasive procedures including blood transfusion
Haemovigilance WHO checklist • Well organized coordinated blood transfusion service • Blood policy and Procedures for the clinical use of blood • Committee on the clinical use of blood • Quality system for the BTS, hospital • Outcomes Monitoring
Saudi National accreditation Program (CBAHI) Requirements • Blood and Blood Components Administrative P&P • Clinical Practice Guidelines For Blood Transfusion • Blood and Blood Components Committee • Blood Transfusion Competency Patient Information Blood Transfusion Auditing ( Risk Monitoring) LD 40.13, LD 10.8 MS 13.2 MS 48 MS 49 NR 6.1.7, NR 8 QM 6.2 QM 24.2 PFR 16.3 LB24 LB 25 LB 27 LB 28 LB 29 LB 30 LB 31 LB 32 LB 33 19
High Risk • Any minor Failure lead to Lethal out come • If Survived Sever Morbidity
M.S.Basharahil Hospital Blood Transfusion Process Indication • “Restricted Indication “ • “Balanced among Benefits versus Risk “ • “Appropriate in Preparedness ( Major Surgeries) ”
M.S.Basharahil Hospital Blood Transfusion Process Policy & Procedures • International References (WHO) • National References –(CBAHI ) • Continuously Updated • Process Mapping • Competency Assessment • Performance Monitoring
M.S.Basharahil Hospital Blood Transfusion Process Blood Transfusion Committee • Approve All P&P • Monitor performance • Establish Solution
Patient Involvements • Pre Transfusion Patient Information • Written Consents
Pre-Transfusion Management • Patient Assessment (Clinical Examination of the patient) • Re-Assessment of BT Needs (Appropriateness of BT) • Adequate Allergic Reaction Precaution
During Transfusion Management Clinical Blood Transfusion Process • Patient/Blood Identification By Resident and Nurse at (BED Side)- • Close Monitoring in the first 15 minutes at a 5 minutes Vital Signs measurement rate • Guidelines to Promptly hold the BT process e,g (Fever Nausea /Skin Rush or any unusual Signs) • Documented form signed and stamped include all steps of transfusion
BT Review • 100% of blood transfusion process are Reviewed and audited by the quality and patient safety department • Summary of the Auditing will be discussed on the BT Committee meeting • Quarterly Performance indicator Measurement ( Dimension Patient Safety )
What Is Next Improvement project for empowering the process of patient/ blood identification Bar-coding Patient Identification and Blood transfusion
Remember Blood Transfusion = Organ Transplantation
Take Home Message • BT Is a high risk Process • Indication must be strict • Guidelines for safety transfusion must be established • Patient Must be involved • Performance during transfusion must be Audited • Vigilance is mandatory • Compliance must be 100%
Dr Abdallah EDDAAL MD.Sps .Hamotology Medical Director Dr Dina BAROUDI MD.PhD.CPHQ Quality Director